Comparison of stable nitroxide, 3-substituted 2,2,5,5-tetramethylpyrrolidine-N-oxyls, with respect to protection from radiation, prevention of DNA damage, and distribution in mice.
We compared three 3-substituted 2,2,5,5-tetramethylpyrrolidine-N-oxyls (PROXYLs): carbamoyl-, methoxycarbonyl-, and hydroxymethyl-PROXYL (CM-, MC-, and HM-PROXYL, respectively) with respect to radioprotection, prevention of DNA damage, and in vivo distribution in mice. The PROXYLs provided protection to C3H mice against lethal X-irradiation (8 Gy) with the following order of magnitude, HM- > CM- approximately MC-PROXYL. In contrast, radioprotection at the cellular level assessed by the colony formation of leukemia cell line L5178Y showed no difference among them. The degree of protection from X ray-induced oxidation of DNA bases measured by the formation of 8-hydroxydeoxyguanosine in salmon DNA and the cleavage of DNA measured by electrophoresis of plasmid pBR322 DNA did not differ among the PROXYLs. Redox potentials were also similar for each. However, the blood concentration of the PROXYLs injected ip into the mice showed different maximum concentrations (HM- > CM- approximately MC-PROXYL), although all reached a maximum at around 5-10 min and gradually decreased thereafter. Their concentration in bone marrow showed a similar pattern, suggesting that the difference in in vivo radioprotection among the three PROXYLs is due to the difference in their distribution to bone marrow. In general, the radioprotection provided by stable nitroxides is affected not only by redox potential and reactivity in vitro but also by pharmacokinetics.
Anzai
Kazunori
K
Redox Regulation Research Group, National Institute of Radiological Sciences, 4-9-1 Anagawa, Chiba 263-8555, Japan. anzai@nirs.go.jp
Ueno
Megumi
M
Yoshida
Akira
A
Furuse
Masako
M
Aung
Winn
W
Nakanishi
Ikuo
I
Moritake
Takashi
T
Takeshita
Keizo
K
Ikota
Nobuo
N
D000080242:8-Hydroxy-2'-Deoxyguanosine; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D001853:Bone Marrow / Q000378:metabolism; D045744:Cell Line, Tumor; D003497:Cyclic N-Oxides / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*; D004247:DNA / Q000528:radiation effects; D004249:DNA Damage / Q000187:drug effects*; D003849:Deoxyguanosine / Q000031:analogs & derivatives / Q000096:biosynthesis; D006339:Heart Rate / Q000187:drug effects; D007940:Leukemia L5178; D008297:Male; D051379:Mice; D010084:Oxidation-Reduction; D010545:Peroxides / Q000494:pharmacology*; D011759:Pyrrolidines / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*; D011837:Radiation-Protective Agents / Q000494:pharmacology*; D012474:Salmon; D014916:Whole-Body Irradiation
D003497:Cyclic N-Oxides; D010545:Peroxides; D011759:Pyrrolidines; D011837:Radiation-Protective Agents; C077426:3-carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidinyl-N-oxyl; D000080242:8-Hydroxy-2'-Deoxyguanosine; D004247:DNA; D003849:Deoxyguanosine